Cad! Blackguard! Bounder! Ming loves these British tourists. Even when they finally notice the tiny a in ROLEXa, they still upgrade Ming from bum to bounder. They're only out twenty bucks or a little more than ten pounds. Victims of the bounders at the FDA are out their lives. Now continuing the flouting of all common sense, maybe, just maybe, if a secondary endpoint like TTP falls beneath the magical and arbitrary 5% to achieve statistical significance as does survival, there is hope for approval, only because TTP was a primary endpoint in previous studies and would be considered supportive. But should only survival itself, for which TTP is a mere surrogate fall under 5% but not to the degree it hits the assigned alpha, then thats no good. Bounders.
May 31, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment